QuidelOrtho
QDEL
A$39.04
Share price
-2.49%
Change (1 day)
-34.40%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : A$5.31 Billion
According to QuidelOrtho's latest financial reports the company's total liabilities are A$5.31 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | A$5.52 B | 5.9% |
| 2023-12-31 | A$5.22 B | -9.39% |
| 2022-12-31 | A$5.76 B | 733.83% |
| 2021-12-31 | A$0.69 B | -1.32% |
| 2020-12-31 | A$0.70 B | 39.66% |
| 2019-12-31 | A$0.50 B | -7.24% |
| 2018-12-31 | A$0.54 B | -40.41% |
| 2017-12-31 | A$0.90 B | 248.49% |
| 2016-12-31 | A$0.26 B | 0.95% |
| 2015-12-31 | A$0.25 B | 4.25% |
| 2014-12-31 | A$0.24 B | 362.41% |
| 2013-12-31 | A$53.48 M | 31.34% |
| 2012-12-31 | A$40.72 M | -55.35% |
| 2011-12-31 | A$91.19 M | -9.25% |
| 2010-12-31 | A$0.10 B | 126.27% |
| 2009-12-31 | A$44.41 M | 32.92% |
| 2008-12-31 | A$33.41 M | 11.77% |
| 2007-12-31 | A$29.89 M | -0.87% |
| 2006-12-31 | A$30.15 M | -17.06% |
| 2005-12-31 | A$36.36 M | 25.02% |
| 2004-12-31 | A$29.08 M | -21.3% |
| 2003-12-31 | A$36.95 M | 4.96% |
| 2002-12-31 | A$35.2 M | -18.26% |
| 2001-12-31 | A$43.07 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Meridian Bioscience VIVO | A$0.14 B | -97.26% | 🇺🇸 USA |
 Becton Dickinson BDX | A$44.85 B | 743.61% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | A$76.04 B | 1,330.44% | 🇺🇸 USA |
 OraSure Technologies OSUR | A$94.1 M | -98.23% | 🇺🇸 USA |
 Danaher DHR | A$43.36 B | 715.70% | 🇺🇸 USA |
 PerkinElmer
PKI | A$10.13 B | 90.63% | 🇺🇸 USA |